Alle verbonden artikelen

Risk stratification of neck lesions detected sonographically during the follow-up of differentiated thyroid cancer.

Auteurs : Lamartina L, Grani G, Biffoni M, Giacomelli L, Costante G, Lupo S, Maranghi M, Plasmati K, Sponziello M, Trulli F, Verrienti A, Filetti S, Durante C
Jaar : 2016
Journal : J Clin Endocrinol Metab
Volume : 101(8)
Pagina's : 3036-44

Histological transformation of ALK rearranged adenocarcinoma into small cell lung cancer: A new mechanism of resistance to ALK inhibitors.

Auteurs : Levacq D, DHaene N, de Wind R, Remmelink M, Berghmans T
Jaar : 2016
Journal : Lung Cancer
Volume : 102
Pagina's : 38-41

le changement dans la continuité.

Auteurs : Berghmans T
Jaar : 2016
Journal : Rev Med Brux
Volume : 37
Pagina's : 3

Innovative perspectives of immunotherapy in head and neck cancer. From relevant scientific rationale to effective clinical practice.

Auteurs : Lalami Y, Awada A
Jaar : 2016
Journal : Cancer Treat Rev
Volume : 43
Pagina's : 113-23

Learning from the tsunami" of immune checkpoint inhibitors in 2015."

Auteurs : Kourie HR, Awada G, Awada A
Jaar : 2016
Journal : Crit Rev Oncol Hematol
Volume : 101
Pagina's : 213-220

Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards.

Auteurs : Bottomley A, Pe M, Sloan J, Basch E, Bonnetain F, Calvert M, Campbell A, Cleeland C, Cocks K, Collette L, Dueck AC, Devlin N, Flechtner HH, Gotay C, Greimel E, Griebsch I, Groenvold M, Hamel JF, King M, Kluetz PG, Koller M, Malone DC, Martinelli F, Mitchell SA, Moinpour CM, Musoro J, OConnor D, Oliver K, Piault-Louis E, Piccart-Gebhart M, Pimentel FL, Quinten C, Reijneveld JC, Schürmann C, Smith AW, Soltys KM, Taphoorn MJ, Velikova G, Coens C
Jaar : 2016
Journal : Lancet Oncol
Volume : 17
Pagina's : e510-e514

The current use and attitudes towards tumor genome sequencing in breast cancer.

Auteurs : Gingras I, Sonnenblick A, de Azambuja E, Paesmans M, Delaloge S, Aftimos P, Piccart-Gebhart M, Sotiriou C, Ignatiadis M, Azim HA Jr
Jaar : 2016
Journal : Sci Rep
Volume : 6
Pagina's : 22517

Clinical relevance of host immunity in breast cancer: from TILs to the clinic.

Auteurs : Savas P, Salgado R, Denkert C, Sotiriou C, Darcy PK, Smyth MJ, Loi S
Jaar : 2016
Journal : Nat Rev Clin Oncol
Volume : 13(4)
Pagina's : 228-41

The thoracic oncology specialist: curriculum recommendations in thoracic oncology training.

Auteurs : Meert AP, Noël JL, Gamarra F
Jaar : 2016
Journal : Eur Respir J
Volume : 48
Pagina's : 628-31

Consensus on precision medicine for metastatic cancers: a report from the MAP conference.

Auteurs : Swanton C, Soria JC, Bardelli A, Biankin A, Caldas C, Chandarlapaty S, de Koning L, Dive C, Feunteun J, Leung SY, Marais R, Mardis ER, McGranahan N, Middleton G, Quezada SA, Rodón J, Rosenfeld N, Sotiriou C, André F
Jaar : 2016
Journal : Ann Oncol
Volume : 27(8)
Pagina's : 1443-8

Cancer des non fumeurs

Auteurs : Berghmans T
Jaar : 2016
Journal : Rev Med Brux
Volume : 8
Pagina's : 411-16

Safety and tolerability of etirinotecan pegol in advanced breast cancer: analysis of the randomized, phase 3 BEACON trial. (Springerplus)

Auteurs : Cortés J, Rugo HS, Twelves C, Awada A, Perez EA, Im SA, Zhao C, Hoch U, Tomkinson D, Buchanan J, Tagliaferri M, Hannah A, OShaughnessy J
Jaar : 2016
Journal : Springerplus
Volume : 5
Pagina's : 1033

Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).

Auteurs : De Grève J, van Meerbeeck J, Vansteenkiste JF, Decoster L, Meert AP, Vuylsteke P, Focan C, Canon JL, Humblet Y, Berchem G, Colinet B, Galdermans D, Bosquée L, Vermeij J, Dewaele A, Geers C, Schallier D, Teugels E
Jaar : 2016
Journal : PLoS One
Volume : 11
Pagina's : e0147599

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR Trial.

Auteurs : Gebhart G, Lamberts LE, Wimana Z, Garcia C, Emonts P, Ameye L, Stroobants S, Huizing M, Aftimos P, Tol J, Oyen WJ, Vugts DJ, Hoekstra OS, Schröder CP, Menke-van der Houven van Oordt CW, Guiot T, Brouwers AH, Awada A, de Vries EG, Flamen P
Jaar : 2016
Journal : Ann Oncol
Volume : 27(4)
Pagina's : 619-24

Near infrared fluorescent imaging after intravenous injection of indocyanine green during neck dissection in patients with head and neck cancer: A feasibility study.

Auteurs : Digonnet A, Moreau M, Willemse E, Quiriny M, de Saint-Aubain de Somerhausen N, Andry G, Bourgeois P
Jaar : 2016
Journal : Head Neck
Volume : 38 sup1
Pagina's : E1833-37

Response to 'Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors?'

Auteurs : Goldrat O, Demeestere I, Azim HA
Jaar : 2016
Journal : Eur J Cancer
Volume : 54
Pagina's : 165-6

Biomarkers for adverse events associated with immune checkpoint inhibitors.

Auteurs : Kourie HR, Paesmans M, Klastersky J
Jaar : 2016
Journal : Biomark Med
Volume : 10
Pagina's : 1029-31

Ex vivo detection of tumoral lymph nodes of colorectal origin with fluorescence imaging after intraoperative intravenous injection of indocyanine green.

Auteurs : Liberale G, Gomez Galdon M, Moreau M, Vankerckhove S, El Nakadi I, Larsimont D, Donckier V, Bourgeois P
Jaar : 2016
Journal : J Surg Oncol
Volume : 114(3)
Pagina's : 348-53

L'euthanasie et la gestion de fin de vie: un débat éthique permanent.

Auteurs : Berghmans T
Jaar : 2016
Journal : Rev Med Brux
Volume : 37(2)
Pagina's : 69

Opioid-free anesthesia: what about patient comfort? A prospective,randomized, controlled trial

Auteurs : Hontoir S, Saxena S, Gatto P, Khalife M, Ben Aziz M, Paesmans M, Sosnowski M
Jaar : 2016
Journal : Acta Anaesthesiol Belg
Volume : 67
Pagina's : 183-190